Nanjing Regenecore Biotech Co., Ltd.

This study is testing whether a new injection called RC1416 can help control moderate to severe COPD. About 180 adults will receive either the injection or a placebo shot every two weeks for one year. Researchers will measure how often participants have serious symptom flare-ups …

This study is testing an investigational injection called RC1416 for adults whose moderate to severe asthma is not well controlled with standard inhalers. About 195 participants will receive either the injection or a placebo to see if it improves lung function and reduces serious…